NDC 65145-135 – Cisatracurium besylate
Cisatracurium Besylate 2 mg/mL · Injection · Intravenous
Product NDC65145-135
Product details
- Brand name
- Cisatracurium besylate
- Generic name
- Cisatracurium besylate
- Labeler
- Caplin Steriles Limited
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- ANDA · ANDA217725
- Marketed since
- January 17, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nondepolarizing Neuromuscular Blocker
Active ingredients
- Cisatracurium Besylate 2 mg/mL
Uses, dosage, side effects and warnings for Cisatracurium Besylate →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 65145-135-01 | 1 VIAL, SINGLE-USE in 1 CARTON (65145-135-01) / 5 mL in 1 VIAL, SINGLE-USE | Jan 17, 2025 |
| 65145-135-10 | 10 VIAL, SINGLE-USE in 1 CARTON (65145-135-10) / 5 mL in 1 VIAL, SINGLE-USE | Jan 17, 2025 |
Other Cisatracurium Besylate products
- 72485-513 Cisatracurium Besylate 200 mg/20mL · Injection · Armas Pharmaceuticals
- 31722-312 Cisatracurium Besylate 10 mg/mL · Injection · Camber Pharmaceuticals Inc.
- 31722-313 Cisatracurium Besylate 2 mg/mL · Injection · Camber Pharmaceuticals Inc.
- 31722-314 Cisatracurium Besylate 2 mg/mL · Injection · Camber Pharmaceuticals Inc.
- 65145-136 Cisatracurium Besylate 2 mg/mL · Injection · Caplin Steriles Limited
- 65145-137 Cisatracurium Besylate 10 mg/mL · Injection · Caplin Steriles Limited
- 55150-286 Cisatracurium Besylate 20 mg/10mL · Injection · Eugia US LLC
- 55150-284 Cisatracurium Besylate 10 mg/5mL · Injection · Eugia US LLC
- 68083-488 Cisatracurium Besylate 2 mg/mL · Injection · Gland Pharma Limited
- 68083-487 Cisatracurium Besylate 10 mg/mL · Injection · Gland Pharma Limited
- 68083-486 Cisatracurium Besylate 2 mg/mL · Injection · Gland Pharma Limited
- 0143-9396 Cisatracurium Besylate 2 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.